Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhibition of NPC1L1 disrupts adaptive responses of drug‐tolerant persister cells to chemotherapy
Zhe Zhang, Siyuan Qin, Yan Chen, et al.
EMBO Molecular Medicine (2022) Vol. 14, Iss. 2
Open Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

Enhancing the therapeutic efficacy of nanoparticles for cancer treatment using versatile targeted strategies
Hailong Tian, Tingting Zhang, Siyuan Qin, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 227
Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management
Ping Jin, Jingwen Jiang, Li Zhou, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 110
Epithelial–mesenchymal transition: The history, regulatory mechanism, and cancer therapeutic opportunities
Zhao Huang, Zhe Zhang, Chengwei Zhou, et al.
MedComm (2022) Vol. 3, Iss. 2
Open Access | Times Cited: 93
Drug-induced oxidative stress in cancer treatments: Angel or devil?
Hao Jiang, Jing Zuo, Bowen Li, et al.
Redox Biology (2023) Vol. 63, pp. 102754-102754
Open Access | Times Cited: 92
Circadian rhythms and cancers: the intrinsic links and therapeutic potentials
Li Zhou, Zhe Zhang, Edouard C. Nice, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 86
Redox signaling at the crossroads of human health and disease
Jing Zuo, Zhe Zhang, Maochao Luo, et al.
MedComm (2022) Vol. 3, Iss. 2
Open Access | Times Cited: 75
Drug-tolerant persister cells in cancer: the cutting edges and future directions
Yi Pu, Lu Li, Haoning Peng, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 11, pp. 799-813
Closed Access | Times Cited: 55
TGF-β, EMT, and resistance to anti-cancer treatment
Xuecong Wang, Pieter J.A. Eichhorn, Jean Paul Thiery
Seminars in Cancer Biology (2023) Vol. 97, pp. 1-11
Open Access | Times Cited: 41
A targeted nanomodulator capable of manipulating tumor microenvironment against metastasis
Hailong Tian, Li Zhou, Yu Wang, et al.
Journal of Controlled Release (2022) Vol. 348, pp. 590-600
Closed Access | Times Cited: 52
Carrier-Free Nanoplatform via Evoking Pyroptosis and Immune Response against Breast Cancer
Lei Li, Hailong Tian, Zhe Zhang, et al.
ACS Applied Materials & Interfaces (2022) Vol. 15, Iss. 1, pp. 452-468
Closed Access | Times Cited: 50
PINK1-Mediated Mitophagy Promotes Oxidative Phosphorylation and Redox Homeostasis to Induce Drug-Tolerant Persister Cancer Cells
Yun Li, Hengxing Chen, Xuan Xie, et al.
Cancer Research (2022) Vol. 83, Iss. 3, pp. 398-413
Open Access | Times Cited: 47
Redox signaling in drug-tolerant persister cells as an emerging therapeutic target
Zhe Zhang, Yunhan Tan, Canhua Huang, et al.
EBioMedicine (2023) Vol. 89, pp. 104483-104483
Open Access | Times Cited: 32
Modulation of redox homeostasis: A strategy to overcome cancer drug resistance
Li Yang, Xiaoyue Zhang, Zhihan Wang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 30
The molecular mechanisms of diapause and diapause-like reversible arrest
Sreesankar Easwaran, Denise J. Montell
Biochemical Society Transactions (2023) Vol. 51, Iss. 5, pp. 1847-1856
Open Access | Times Cited: 26
Drug tolerant persister cell plasticity in cancer: A revolutionary strategy for more effective anticancer therapies
Jun He, Zejing Qiu, Jingjing Fan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 8
Clinical applications of plasma proteomics and peptidomics: Towards precision medicine
Bo He, Zhao Huang, Canhua Huang, et al.
PROTEOMICS - CLINICAL APPLICATIONS (2022) Vol. 16, Iss. 6
Closed Access | Times Cited: 36
A Tale of Two Cancers: A Current Concise Overview of Breast and Prostate Cancer
Franklyn De Silva, Jane Alcorn
Cancers (2022) Vol. 14, Iss. 12, pp. 2954-2954
Open Access | Times Cited: 35
Disrupting metformin adaptation of liver cancer cells by targeting the TOMM34/ATP5B axis
Ping Jin, Jingwen Jiang, Li Zhou, et al.
EMBO Molecular Medicine (2022) Vol. 14, Iss. 12
Open Access | Times Cited: 28
A minimalist and robust chemo-photothermal nanoplatform capable of augmenting autophagy-modulated immune response against breast cancer
Hui Ming, Bowen Li, Hailong Tian, et al.
Materials Today Bio (2022) Vol. 15, pp. 100289-100289
Open Access | Times Cited: 27
The Cancer Antioxidant Regulation System in Therapeutic Resistance
Xuanhao Gu, Chunyang Mu, Rujia Zheng, et al.
Antioxidants (2024) Vol. 13, Iss. 7, pp. 778-778
Open Access | Times Cited: 5
Unraveling the underlying mechanisms of cancer stem cells in therapeutic resistance for optimizing treatment strategies
Yunhan Tan, Siyuan Qin, Zhe Zhang, et al.
MedComm – Oncology (2025) Vol. 4, Iss. 1
Open Access
Dual targeting PPARα and NPC1L1 metabolic vulnerabilities blocks tumorigenesis
Xiaona You, Xi Hu, Zenghui Sun, et al.
Cancer Letters (2025), pp. 217493-217493
Closed Access
Nanoparticle troopers: Infiltrating cancer cells for targeted therapies
Shivam Rajput, Rishabha Malviya, Sankha Bhattacharya, et al.
Nano-Structures & Nano-Objects (2025) Vol. 41, pp. 101453-101453
Closed Access
Nutraceutical Evaluation of Trigonelline's Therapeutic Potential by Targeting Bladder Cancer Stem Cells and Cancer-Associated Fibroblasts via Downregulation of TGFβ3/GLI2/YAP1 Signaling Hub
Chien‐Chang Kao, Jing-Wen Shih, Huong Thi Luu Kim Huynh, et al.
International Journal of Medical Sciences (2025) Vol. 22, Iss. 5, pp. 1194-1207
Open Access
Page 1 - Next Page

Scroll to top